RNS Number : 5497O
Spectra Systems Corporation
13 June 2022
 

Spectra Systems Corporation

("The Company" or "Spectra")

Annual General Meeting Lack of Quorum

Spectra (AIM: SPSY.L) announces that, having received only 9 ballots, it does not have enough shareholder votes to achieve a quorum to transact business at its scheduled 2022 Annual General Meeting on 13 June 2022. The presence in person or by proxy, duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote constitutes a quorum.

A summary of the votes received is as follows:

Resolution

For

Against

Discretion

Withheld

Total

Elect BJ Penn as Director

12,345,133

-

-

6,441,048

18,786,181

Elect Nabil Lawandy as Director

17,431,307

-

-

1,354,874

18,786,181

Elect Jeremy Fry as Director

17,431,307

-

-

1,354,874

18,786,181

Elect Donald Stanford as Director

12,345,133

-

-

6,441,048

18,786,181

Ratification of Appointment of Independent Auditor

17,431,307

1,354,874

-

-

18,786,181

Total shares of stock outstanding as of the record date of 10 June, 2022 was 45,320,439. Therefore, only approximately 41% of the shares of stock were voted.                    

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy (Chief Executive Officer)                                     Tel: +1 (0) 401 274 4700

 

WH Ireland Limited (Nominated Adviser and Broker)

Chris Fielding (Managing Director, Corporate Finance)

Andrew de Andrade (Executive, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 7220 1650

 

 

 

Tel: +44 (0)20 3328 5665

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKBLFFLQLLBBD